Journal
/
/
Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening
Journal JoVE
Bio-ingénierie
Un abonnement à JoVE est nécessaire pour voir ce contenu.  Connectez-vous ou commencez votre essai gratuit.
Journal JoVE Bio-ingénierie
Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening
DOI:

10:39 min

April 15, 2017

, , , , , ,

Chapitres

  • 00:05Titre
  • 01:05Engineering Heart Tissue (EHT) Generation
  • 03:40Contraction Analysis
  • 05:48Drug Screening
  • 08:20Results: Representative EHT Contraction Analysis
  • 09:32Conclusion

Summary

Traduction automatique

Here, we show the generation of human engineered heart tissue from induced pluripotent stem cells (hiPSC)-derived cardiomyocytes. We present a method to analyze contraction force and exemplary alteration of contraction pattern by the hERG channel inhibitor E-4031. This method shows high level of robustness and suitability for cardiac drug screening.

Vidéos Connexes

Read Article